logo-loader

ProMetic Life Sciences Inc.

Receive alerts
Market:
TSX
Market Cap:
$317.06 m
Price
13.60 CAD
Change
0.22%
52 weeks high
590.00
52 weeks low
7.13

In brief

ProMetic Life Sciences Inc. ("ProMetic") is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand(TM) technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer.